Immune cell helps predict skin cancer patients' chances of responding to treatment

byKing's College Londona, Schematic of nonenzymatic extraction of lymphocytes from primary human tissue and subsequent expansion protocol. b, Summary flow cytometry data of Vδ1+cell en

Updated on: January 26,2024

Immune cell helps predict skin cancer patients' chances of responding to treatment

byKing's College Londona, Schematic of nonenzymatic extraction of lymphocytes from primary human tissue and subsequent expansion protocol. b, Summary flow cytometry data of Vδ1+cell en

Updated on:January 26,2024

Cancer diagnoses dropped sharply in Alberta during COVID-19 response

by Canadian Medical Association JournalCredit: Unsplash/CC0 Public DomainPandemic restrictions corresponded with a significant drop in diagnoses of breast, colorectal and prostate cancers as well

Updated on: February 20,2024

Cancer diagnoses dropped sharply in Alberta during COVID-19 response

by Canadian Medical Association JournalCredit: Unsplash/CC0 Public DomainPandemic restrictions corresponded with a significant drop in diagnoses of breast, colorectal and prostate cancers as well

Updated on:February 20,2024

Breast cancer: An aggressive variant triggers a hunt for cures

by Vittoria D'alessio,Horizon: The EU Research & Innovation MagazineResearchers are making progress finding treatments for a particularly aggressive variant of breast cancer. Credit: Ang

Updated on: January 03,2024

Breast cancer: An aggressive variant triggers a hunt for cures

by Vittoria D'alessio,Horizon: The EU Research & Innovation MagazineResearchers are making progress finding treatments for a particularly aggressive variant of breast cancer. Credit: Ang

Updated on:January 03,2024

A non-coding RNA lasso catches proteins in breast cancer cells

by Lisbeth Heilesen,Aarhus UniversityThe authors show that the long non-coding RNA called A-ROD (Activating Regulator Of DKK1 expression) is only functional the moment it is released from chroma

Updated on: May 20,2024

A non-coding RNA lasso catches proteins in breast cancer cells

by Lisbeth Heilesen,Aarhus UniversityThe authors show that the long non-coding RNA called A-ROD (Activating Regulator Of DKK1 expression) is only functional the moment it is released from chroma

Updated on:May 20,2024

New therapies have raised Medicare treatment costs for metastatic prostate cancer

byWolters Kluwer HealthTrends in the receipt of antineoplastic drugs in the first 2 years following patients’ index date. The height of the bar represents the proportion of patients receiving do

Updated on: January 15,2024

New therapies have raised Medicare treatment costs for metastatic prostate cancer

byWolters Kluwer HealthTrends in the receipt of antineoplastic drugs in the first 2 years following patients’ index date. The height of the bar represents the proportion of patients receiving do

Updated on:January 15,2024

Symptoms of Non-Small Cell Lung Cancer

Updated on: January 28,2024

Symptoms of Non-Small Cell Lung Cancer

Updated on:January 28,2024

Researchers unlock mysteries of complex microRNA oncogenes

by McGill UniversityMicroRNA and mRNA visualization in differentiating C1C12 cells. Credit: Ryan Jeffs/WikipediaMicroRNAs are tiny molecules of nucleic acid that control gene expression, acting l

Updated on: June 11,2024

Researchers unlock mysteries of complex microRNA oncogenes

by McGill UniversityMicroRNA and mRNA visualization in differentiating C1C12 cells. Credit: Ryan Jeffs/WikipediaMicroRNAs are tiny molecules of nucleic acid that control gene expression, acting l

Updated on:June 11,2024

Double trouble for triple-negative breast cancer: Two-pronged strategy restores immunotherapy sensitivity

by Kimberly McGhee,Medical University of South CarolinaTumor-fighting immune cells in the tumor before (left) and after (right) combination therapy. After combination therapy, many more tumor-fi

Updated on: September 27,2024

Double trouble for triple-negative breast cancer: Two-pronged strategy restores immunotherapy sensitivity

by Kimberly McGhee,Medical University of South CarolinaTumor-fighting immune cells in the tumor before (left) and after (right) combination therapy. After combination therapy, many more tumor-fi

Updated on:September 27,2024

Therapeutic vaccine shows promise against a range of cancers

by Serena Gordon, Healthday Reporter(HealthDay)—A personalized vaccine held an aggressive group of cancers in check among more than half of patients who received it in a small, preliminary trial, rese

Updated on: April 09,2024

Therapeutic vaccine shows promise against a range of cancers

by Serena Gordon, Healthday Reporter(HealthDay)—A personalized vaccine held an aggressive group of cancers in check among more than half of patients who received it in a small, preliminary trial, rese

Updated on:April 09,2024

Active surveillance feasible for low-risk thyroid cancer

Active surveillance may be a viable strategy for most diagnosed thyroid cancers, according to a study published online Sept. 15 inJAMA Oncology.Allen S. Ho, M.D., from Cedars-Sinai Medical Cente

Updated on: January 21,2024

Active surveillance feasible for low-risk thyroid cancer

Active surveillance may be a viable strategy for most diagnosed thyroid cancers, according to a study published online Sept. 15 inJAMA Oncology.Allen S. Ho, M.D., from Cedars-Sinai Medical Cente

Updated on:January 21,2024

Tumor-infiltrating lymphocyte therapy marks a milestone in cancer treatment, researchers say

byH. Lee Moffitt Cancer Center & Research InstituteCancer cell during cell division. Credit: National Institutes of HealthThe recent U.S. Food and Drug Administration approval of lifileucel,

Updated on: August 03,2024

Tumor-infiltrating lymphocyte therapy marks a milestone in cancer treatment, researchers say

byH. Lee Moffitt Cancer Center & Research InstituteCancer cell during cell division. Credit: National Institutes of HealthThe recent U.S. Food and Drug Administration approval of lifileucel,

Updated on:August 03,2024

New antibody harbors great potential for fighting blood cancer

byKiel UniversityCredit:Blood(2024). DOI: 10.1182/blood.2023021088Acute lymphoblastic leukemia (ALL) is the most common cancer in children. This form of blood cancer, which also occu

Updated on: July 08,2024

New antibody harbors great potential for fighting blood cancer

byKiel UniversityCredit:Blood(2024). DOI: 10.1182/blood.2023021088Acute lymphoblastic leukemia (ALL) is the most common cancer in children. This form of blood cancer, which also occu

Updated on:July 08,2024